TickerFacts.

Agentix Corp. (AGTX): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$108.5K
Year ended 2026-03-31
-$16.5K
Trailing 12 months to 2026-06-30
2014-08-31: -$193.9K2015-08-31: -$186.9K2016-08-31: -$12.6K2017-08-31: -$76.4K2018-08-31: -$51.6K2019-08-31: -$62.0K2022-03-31: -$25.2K2023-03-31: -$88.5K2024-03-31: -$110.4K2025-03-31: -$125.1K2026-03-31: -$108.5K-$108.5K
2014-08-31 Operating Cash Flow (USD) 2026-03-31
Period endedOperating Cash FlowChange YoYSource filing
2026-03-31-$108.5Kn/m2026-07-01, From 2025-04-01
2025-03-31-$125.1Kn/m2026-07-01, From 2024-04-01
2024-03-31-$110.4Kn/m2025-07-16, From 2023-04-01
2023-03-31-$88.5Kn/m2024-08-30, From 2022-04-01
2022-03-31-$25.2Kn/a2023-07-14, From 2021-04-01
No annual figure between 2019-08-31 and 2022-03-31.
2019-08-31-$62.0Kn/m2019-12-05, From 2018-09-01
2018-08-31-$51.6Kn/m2019-12-05, From 2017-09-01
2017-08-31-$76.4Kn/m2018-11-13, From 2016-09-01
2016-08-31-$12.6Kn/m2017-12-18, From 2015-09-01
2015-08-31-$186.9Kn/m2016-12-12, From 2014-09-01
2014-08-31-$193.9Kn/a2015-12-16, From 2013-09-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Agentix Corp. (AGTX)2026-03-31-$108.5Kn/m
Mosaic ImmunoEngineering Inc. (CPMV)2025-12-31-$111.4Kn/m
Liminatus Pharma, Inc. (LIMN)2025-12-31-$9.96Mn/m
Adaptin Bio, Inc. (APTN)2025-12-31-$4.78Mn/m
Brainstorm Cell Therapeutics Inc. (BCLI)2025-12-31-$6.97Mn/m
Abpro Holdings, Inc. (ABPO)2025-12-31-$6.01Mn/m
Zeo ScientifiX, Inc. (ZEOX)2025-10-31-$718.0Kn/m
Zivo Bioscience, Inc. (ZIVO)2024-12-31-$4.31Mn/m
Estrella Immunopharma, Inc. (ESLA)2025-12-31-$1.79Mn/a

Compare AGTX, CPMV, LIMN, APTN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗